Sexual Difficulties Common in Young Cancer Survivors, Study Finds

A new doctoral study from Karolinska Institutet reveals that young adults often experience sexual problems after cancer treatment, with severity varying by cancer type and treatment intensity.

May 27, 2026
Sexual Difficulties Common in Young Cancer Survivors, Study Finds

A new doctoral study from Sweden's Karolinska Institutet has found that sexual difficulties are common among young people who have survived cancer treatment. The nature and severity of those difficulties shift considerably based on cancer type and how intensively the patient was treated.

Charlotta Bergström, a nurse and doctoral student at the Karolinska Institutet, led the research, which covered more than 1,000 patients. The findings highlight a significant quality-of-life issue for young cancer survivors, a demographic often overlooked in discussions about long-term treatment side effects.

The study underscores the need for better supportive care and potentially for therapies with fewer adverse effects. As companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) continue with their efforts geared toward developing the next generation of medications indicated for brain cancer, there is hope that the treatments they commercialize could have a better safety profile and fewer side effects impacting sexual function.

The implications of this research are significant for both patients and healthcare providers. Young adults who survive cancer often face a lifetime of managing treatment aftermath, and sexual health is a critical component of overall well-being. The study suggests that clinicians should proactively address these issues with patients, rather than waiting for them to raise concerns.

Moreover, the findings could influence how new cancer therapies are evaluated. Drug developers may need to consider sexual side effects as a key outcome in clinical trials, especially for treatments aimed at younger populations. This could drive innovation in creating drugs that target cancer cells more precisely while sparing healthy tissues responsible for sexual function.

The research also points to disparities in sexual difficulties based on cancer type. Patients with certain cancers may be at higher risk and require tailored interventions. For example, those treated for testicular or ovarian cancer may face unique challenges compared to survivors of leukemia or lymphoma.

As the field of oncology advances, studies like this one emphasize the importance of a holistic approach to cancer care. Surviving cancer is not just about eradicating the disease; it is also about ensuring that survivors can lead fulfilling lives afterward. The Karolinska Institutet study provides a foundation for further research into how to mitigate long-term sexual side effects and improve patient quality of life.

For more information on the study and its implications, visit the Karolinska Institutet's website or follow developments in cancer survivorship research.